Drug Shortage Report for ACYCLOVIR SODIUM INJECTION
| Report ID | 122380 |
| Drug Identification Number | 02236926 |
| Brand name | ACYCLOVIR SODIUM INJECTION |
| Common or Proper name | Acyclovir Sodium Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ACYCLOVIR |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2020-08-14 |
| Estimated end date | 2020-12-31 |
| Actual end date | 2021-01-05 |
| Shortage status | Resolved |
| Updated date | 2021-01-06 |
| Company comments | Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials 1/06/21 Fresenius Kabi Canada Ltd. is pleased to advise that our Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL will be available at Ontario distribution centers today, Tuesday, January 5, 2021 and at all other distribution centers by Friday, January 8, 2021. Our Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL will also be available at Ontario distribution centers on Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-01-06 | French | Compare |
| v3 | 2021-01-06 | English | Compare |
| v2 | 2020-08-17 | French | Compare |
| v1 | 2020-08-17 | English | Compare |
Showing 1 to 4 of 4